Shiguang Zhu
20 Yuhuangding East Road
Yantai, 264000, China
Yantai, 264000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab plus chemotherapy for early-stage triple-negative breast cancer: a experimental single-arm phase II clinical trial pilot study.
Journal: International journal of surgery (London, England)
Published: September 12, 2023
Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case-Control Study in Chinese Females.
Journal: Frontiers in oncology
Published: November 05, 2021
MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells.
Journal: Experimental and therapeutic medicine
Published: September 10, 2021
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: November 23, 2020
Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer.
Journal: Frontiers in oncology
Published: May 27, 2020
Fascia Suture Technique Is a Simple Approach to Reduce Postmastectomy Seroma Formation.
Journal: Journal of breast cancer
Published: April 18, 2020
Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia.
Journal: Psychoneuroendocrinology
Published: June 18, 2019
Efficacy of neoadjuvant chemotherapy and Annexin A3 expression in breast cancer.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: May 26, 2019
Imaging Predictors for Nonsentinel Lymph Node Metastases in Breast Cancer Patients.
Journal: Breast care (Basel, Switzerland)
Published: January 24, 2019
Association of PTPN1 polymorphisms with breast cancer risk: A case-control study in Chinese females.
Association of PTPN1 polymorphisms with breast cancer risk: A case-control study in Chinese females.
Journal: Journal of cellular biochemistry
Published: December 17, 2018
CD21lo/medCD27+ proinflammatory B cells are enriched in breast cancer patients and promote antitumor T cell responses.
Journal: Experimental cell research
Published: August 17, 2017
Last Updated: 09/26/2026